Droplet Biosciences can offer earlier and more accurate cancer diagnosis by using lymphatic fluid.
Droplet Biosciences has raised $8.0M in total funding. The most recent round was Seed. The last funding was announced in March 2023.
Droplet Biosciences's investors include The Engine, North South Ventures.
Droplet Biosciences is headquartered in Cambridge, United States.
Droplet Biosciences can offer earlier and more accurate cancer diagnosis by using lymphatic fluid.
Droplet Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Droplet Biosciences — Funding & Investors." VCBacked, March 16, 2023, https://www.vcbacked.co/company/droplet-biosciences. Accessed October 30, 2026.
VCBacked. (2023). Droplet Biosciences — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/droplet-biosciences
{{cite web |title=Droplet Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/droplet-biosciences |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated